FDA grants AP status for Glyburide and Metformin Hydrochloride by Impax
The FDA has granted Abbreviated Approval (AP) status for Glyburide and Metformin Hydrochloride submitted by Impax under application ANDA076345.
Therapeutic Area
Therapeutic area intelligence for Oral Hypoglycemic Agents with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.